Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones

被引:166
作者
Evans, MJ [1 ]
Livesey, JH [1 ]
Ellis, MJ [1 ]
Yandle, TG [1 ]
机构
[1] Christchurch Hosp, Dept Endocrinol, Endolab, Christchurch, New Zealand
关键词
plasma; storage; hormones; anticoagulant; serum; temperature; stability;
D O I
10.1016/S0009-9120(01)00196-5
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To determine the effect of different anticoagulants and storage conditions on the stability of hormones in plasma and serum. Design and methods: Human blood samples were collected from volunteers into EDTA, lithium heparin, sodium fluoride/potassium oxalate, or tubes without anticoagulant, plasma and serum left at -20 degreesC, 4 degreesC or 30 degreesC for 24 and 120 hours then assayed for ACTH, aldosterone, alpha -subunit, AVP, CRH. C-peptide, estradiol, FSH, glucagon, GH, ICF-1, IGFBP-3, insulin, leptin, LH, PPP, PTH, prolactin and VIP, or at room temperature for 0 to 72 hours (BNP, NT-BNP)(n = 6 per condition). Results: The anticoagulant altered the measured concentrations for 9 hormones when compared to EDTA. All hormones except ACTH were stable for > 120 hours in EDTA or fluoride at 4 degreesC, but only 13 hormones were stable in all anticoagulants. At 30 degreesC, X hormones were stable for > 120 hours in EDTA, and 3 hormones in all anticoagulants. BNP and NT-BNP were stable for < 24 hours when stored in EDTA or heparin at room temperature. Discussion: Storage of samples in EDTA plasma at 4 degreesC is suitable for most hormones (except ACTH) for up to 120 hours. (C) 2001 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 17 条
[1]   Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice [J].
Buckley, MG ;
Marcus, NJ ;
Yacoub, MH ;
Singer, DRJ .
CLINICAL SCIENCE, 1998, 95 (03) :235-239
[2]   THE LONG-TERM STABILITY IN WHOLE-BLOOD OF 14 COMMONLY-REQUESTED HORMONE ANALYTES [J].
DIVER, MJ ;
HUGHES, JG ;
HUTTON, JL ;
WEST, CR ;
HIPKIN, LJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 1994, 31 :561-565
[3]  
DONALD RA, 1977, HDB RADIOIMMUNOASSAY, P319
[4]   Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro:: implications for assessment of left ventricular dysfunction [J].
Downie, PF ;
Talwar, S ;
Squire, IB ;
Davies, JE ;
Barnett, DB ;
Ng, LL .
CLINICAL SCIENCE, 1999, 97 (03) :255-258
[5]   CIRCULATING PLASMA CORTICOTROPHIN-RELEASING FACTOR-LIKE IMMUNOREACTIVITY [J].
ELLIS, MJ ;
LIVESEY, JH ;
DONALD, RA .
JOURNAL OF ENDOCRINOLOGY, 1988, 117 (02) :299-307
[6]   PLASMA CORTICOTROPIN-RELEASING FACTOR AND VASOPRESSIN RESPONSES TO HYPOGLYCEMIA IN NORMAL MAN [J].
ELLIS, MJ ;
SCHMIDLI, RS ;
DONALD, RA ;
LIVESEY, JH ;
ESPINER, EA .
CLINICAL ENDOCRINOLOGY, 1990, 32 (01) :93-100
[7]   Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment [J].
Hunt, PJ ;
Richards, AM ;
Nicholls, MG ;
Yandle, TG ;
Doughty, RN ;
Espiner, EA .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :287-296
[8]  
Karl J, 1999, SCAND J CLIN LAB INV, V59, P177
[9]  
KUBASIK NP, 1982, CLIN CHEM, V28, P164
[10]   PREPARATION AND IMMUNOLOGICAL PROPERTIES OF 1331I-LABELLED ADRENOCORTICOTROPHIN [J].
LANDON, J ;
LIVANOU, T ;
GREENWOOD, FC .
BIOCHEMICAL JOURNAL, 1967, 105 (03) :1075-+